SpicyIP Tidbit: India 2nd Largest User of PCT Among Developing Countries

/ By / Others, Patent

A press release by WIPO on 13th March, 2014 reveals that 2013 saw new records being broken when more than 200,000 international patent applications were filed in a single year, for the first time. Records were also broken in international trademark and industrial design filings. International Patent Applications are filed under the Patent Cooperation Treaty (PCT). While the USA (with 57,239 applications) and Japan (with 43,918 applications) predictably filed the highest number of patent applications, India has emerged the 2nd […]

SpicyIP Tidbit: India 2nd Largest User of PCT Among Developing Countries Read More »

Delhi High Court Denies ‘India Today’ Temporary Injunction Regarding Trademark Over the Word ‘Today’

/ By / Trademark

Living Media Ltd (“India Today Group”) had filed an application for interim injunction in front of the Delhi High Court restraining Alpha Dealcom from launching a news channel with the name ‘Nation Today’, contending that the latter’s usage over the word ‘Today’ infringed on their trademark over the same. The Delhi High Court held that there was no prima facie infringement as the usage of the word by the two parties was not likely to cause confusion in the minds

Delhi High Court Denies ‘India Today’ Temporary Injunction Regarding Trademark Over the Word ‘Today’ Read More »

Trademark Parallel Imports: Delhi HC on the Marlboro Trademark case

/ By / Trademark

People say that the world isn’t “black and white”; that there are many shades in between, of which, the grey areas usually raise difficult questions. This belief applies even in the world of Intellectual Property Rights. Parallel imports i.e. lawful import of a genuine trademarked product without the permission of the proprietor thereby creating a trade channel that runs parallel to the proprietors authorized trade channel, is usually called a ‘grey market’ import (see here). Such imports are not ‘black’

Trademark Parallel Imports: Delhi HC on the Marlboro Trademark case Read More »

WIPO-WTO Colloquium for Teachers of Intellectual Property

/ By / Others

The WIPO and WTO are jointly organising a two week colloquium from June 16-27, 2014 for teachers of intellectual property from developing countries and countries with economies in transition in Geneva. The colloquium is aimed at being a multidisciplinary activity open to lawyers, researchers, university teachers and economists working in the field. The curriculum for the colloquium and other details can be viewed here. The eligibility criteria is an advanced degree and teaching experience in IP law or international law/economics/management

WIPO-WTO Colloquium for Teachers of Intellectual Property Read More »

SpicyIP Weekly Review (3rd-9th March, 2014)

/ By / Others

  This week, SpicyIP covered an array of topics ranging across the spectrum of IP Law. The SpicyIP story of the week is Aparajita’s post covering the report by the National Council of Applied Research on Impact of Parallel Import on Copyrighted Works. It was opined that this report balances the concerns of producers and consumers, and urges stakeholders to come to an amicable solution, failing which an addition of the proviso to S.2(m) of the Copyright Act would be

SpicyIP Weekly Review (3rd-9th March, 2014) Read More »

Taking IP on a spin – round 1

/ By / Innovation, Patent

The lines below (emphasis: mine) are taken out of a letter (see here) dated August 2nd, 2013 sent by 4 US Senators requesting the US International Trade Commission (USITC) to investigate India’s international trade (read: IP) policies. “Based on the survey and analysis of results, and to the extent feasible, a summary of U.S. firms’ perception of (1) recent changes in India’s trade and investment policies in selected sectors and (2) the effects of these changes on U.S. firms’ strategies towards India …”

Taking IP on a spin – round 1 Read More »

Revisiting Patentability of Computer Programs and Section 3(k): A Different Perspective

/ By / Patent

This post continues from my previous (academic) posts on the topic re patentability of software, and provides an academic reasoning of what constitutes software / computer programme per se. The reason why I am limiting the issue only to the term software per se is because of the recent discussions draft guidelines issued by our Patent Office on the topic, and the subsequent discussions on the same.   As we know that the term per se did not come into the

Revisiting Patentability of Computer Programs and Section 3(k): A Different Perspective Read More »

Teva loses in the patent battle against NATCO

/ By / Patent

Introduction The Delhi HC, in a recent judgment, returned the plaint filed by Teva Pharmaceuticals Industries Ltd. (“Teva”), Yeda Research and Development Co. Ltd. (“Yeda”) and Teva API India Limited (“Plaintiffs”) seeking permanent injunction for restraining NATCO from manufacturing Glatiramer Acetate product (Copaxone) for sale in the US. It was held that the Court did not enjoy the jurisdiction to entertain the suit. For BusinessLine report, see here. [Glatiramer Acetate (also known as Copolymer 1, Cop-1 or Copaxone – as marketed by Teva Pharmaceuticals) is

Teva loses in the patent battle against NATCO Read More »

NCAER Report on Parallel Imports OUT!

/ By / Copyright

The National Council of Applied Economic Research has released its much awaited report on the Impact of Parallel Imports on Copyrighted Works. Stakeholders can send in comments by 21st March 2014 and comments will be reviewed by the NCAER on 26th March 2014. The report adequately considers the opposing views of the producers as well as the consumers. It also urges all the stakeholders to amicably, through a healthy exchange of views, come to an optimal solution to the parallel

NCAER Report on Parallel Imports OUT! Read More »

Weekly Review (24th February to 2nd March)

/ By / Others

The SpicyIP highlight of the week is Thomas’ post on Rare diseases and innovation. We chose it as the highlight of the week as it brings to light an often under-discussed topic in the pharma patent world, while also being a stark example of an area that the patent system is currently ill-equipped to deal with. The last week was a busy one for our blog with some very interesting IP developments both in India as well as internationally. We

Weekly Review (24th February to 2nd March) Read More »

Scroll to Top